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Transient expression of the bHLH factor neurogenin-2
marks a subpopulation of neural crest cells biased
for a sensory but not a neuronal fate
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*Division of Biology 216-76, †Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125; and ‡Department of Molecular and
Cellular Biology, Harvard University, Cambridge, MA 02138
Communicated by Douglas A. Melton, Harvard University, Cambridge, MA, April 16, 2002 (received for review February 6, 2002)
Lineage-tracing experiments have indicated that some premigra-
tory neural crest cells (NCCs) are pleuripotent, generating sensory
and sympathetic neurons and their associated glia. Using an
inducible Cre recombinase-based fate mapping system, we have
permanently marked a subpopulation of NCCs that expresses
Ngn2, a bHLH transcription factor required for sensory neurogen-
esis, and compared its fate to the bulk NCC population marked by
expression of Wnt1. Ngn2 progenitors were four times more
likely than Wnt1 NCCs to contribute to sensory rather than
sympathetic ganglia. Within dorsal root ganglia, however, both
Ngn2- and Wnt1-expressing cells were equally likely to generate
neurons or glia. These data suggest that Ngn2 marks an NCC
subpopulation with a predictable fate bias, early in migration.
Taken together with previous work, these data suggest that NCCs
become restricted to sensory or autonomic sublineages before
becoming committed to neuronal or glial fates.
The neural crest presents a model system for studying neuralcell lineage segregation. Neural crest cells (NCCs) generate
the sensory and autonomic neurons of the peripheral nervous
system, and their associated glia, after migrating from the
dorsolateral neural tube (1). Single-cell lineage-marking exper-
iments in vivo have indicated that some premigratory trunk
NCCs are pleuripotent, generating neurons and glia in both
sensory and autonomic (sympathetic) ganglia (2–4). However in
these experiments, other NCCs generated only a subset of these
derivatives—e.g., in sensory but not autonomic ganglia. Because
the marked cells were selected at random, it could not be
distinguished whether NCCs are homogeneous and pleuripotent,
but exhibit heterogeneity in their fates because of stochastic
variation, or rather are heterogeneous and comprise subpopu-
lations with deterministic fate restrictions that could not be
prospectively identified. Lineage-marking studies performed on
migrating NCCs in vitro have revealed evidence of rapid restric-
tion to neuronal or glial fates (5), but the neuronal subtype(s)
involved were not examined.
Evidence of molecular heterogeneity among early NCCs has
been suggested by the often transient expression of various
antigenic markers and genes (reviewed in ref. 1; e.g., ref. 6).
However, without some way to convert the expression of such
markers into a permanent lineage tracer, it remained unclear
whether this heterogeneity reflected early fate-specification.
Here we have achieved such a conversion by using a conditional
form of Cre recombinase to permanently mark a subset of NCCs
that transiently express the proneural bHLH transcription factor
Neurogenin2 (Ngn2) (7, 8). Ngn2 is required for the differenti-
ation of a subset of sensory neurons (9), but is dispensable for
autonomic neurons and for Schwann (glial) cells in peripheral
nerves (10). The genetic requirement for Ngn2 in sensory
neurons, however, leaves open the question of whether it is
expressed by progenitors restricted to a sensory neuron fate (Fig.
1A 4), or rather by cells with a broader developmental potential
(Fig. 1A 1–3).
To address this question, we have used a conditional, binary
system for fate-mapping of Ngn2-expressing progenitor cells in
vivo based on Cre-lox-mediated DNA recombination (11, 12).
We have expressed a 4-hydroxy tamoxifen (4-OH Txf)-inducible
form of Cre recombinase, CreERTM (12–14), from Ngn2
genomic regulatory elements in mice (Fig. 1B). Such Ngn2-
CreERTM mice are then crossed to mice carrying a ubiquitously
expressed, Cre-dependent lacZ reporter gene (15). In embryos
from this intercross, lacZ expression can be activated only in
Ngn2-expressing progenitors. Because activation of the reporter
gene involves a cell-heritable DNA rearrangement event, lacZ
expression will persist in the progeny of transiently Ngn2-
expressing cells (Fig. 1C). Because 4-OH Txf has a half-life of
only 0.5–2 h in vivo (12), activation of CreERTM can be further
restricted to a relatively narrow developmental time window
when the ligand is injected. Thus, the final expression pattern of
the lacZ reporter will exclusively identify the progeny of cells
expressing Ngn2-CreERTM during this time window, and will not
include cells that express Ngn2 at later times (Fig. 1C, large lower
oval).
Materials and Methods
Mouse Manipulations. Homologous recombination in embryonic
stem cells was used to replace the Ngn2 coding sequence with
CreERTM (12), by means of the same strategy used to generate
Ngn2 knockouts (10). Ngn2-CreERTM mice bred into a C57Bl6J
background were crossed to Rosa26-loxp reporter mice (15) to
generate embryos for analysis. In other experiments, mice
harboring a Wnt1-CreERTM transgene (12) were bred to the same
line of reporter mice. 4-OH Txf was injected i.p. (1 mg per
mouse) to activate Cre-ERTM. Injections to activate CreERTM at
embryonic day (E)8.75–E9.0 were performed between 5 p.m.
and midnight (counting the morning, the vaginal plug was
identified as E0.5), and to activate it at E9.5 were performed
between 8 a.m. and noon the following day. Embryos were
analyzed at E12.5, or in some experiments at E10.5.
Histology. Embryos were fixed in 4% paraformaldehyde (PFA)
for 1–2 h at room temperature, embedded, frozen, and sectioned
at 15 m. For double-labeling (16), sections were first X-gal-
stained (17), post-fixed in 4% PFA, preblocked, and then
incubated for 1.5 h at room temperature with the appropriate
primary antibodies: mouse monoclonal anti-Isl-1 (IgG1, Devel-
opmental Studies Hybridoma Bank, 1:1 dilution); rabbit anti-TH
(Sigma, 1:1,000 dilution); rabbit anti-brain fatty acid binding
protein (BFABP; C. Birchmeier, Max Delbru¨ck Centrum for
Molecular Medicine, Berlin; 1:1,000 dilution); rabbit anti-trk-A
(L. Reichardt, University of California, San Francisco; 1:2,000
dilution); rabbit anti-trk-B (L. Reichardt, 1:1,000 dilution); goat
Abbreviations: DRG, dorsal root ganglia; SG, sympathetic ganglia; NCCs, neural crest cells;
4-OH Txf, 4-hydroxy tamoxifen; BFABP, brain fatty acid binding protein; E, embryonic day.
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anti-trk-C (L. Reichardt, 1:500 dilution). Antibody staining was
developed with diaminobenzidine by using the Vecstatin ABC
kit (Vector Laboratories). Fluorescent secondary antibodies
were Alexa red anti-rabbit (Molecular Probes) or FITC-
conjugated anti-mouse IgG1 (Southern Biotechnology Associ-
ates, 1:250 dilution).
Results
In E9.5 embryos, NGN2 is expressed in both the dorsal neural
tube (Fig. 2 A and C; white arrowheads), and in a subset of
migrating NCCs marked by Sox10 (refs. 18 and 19; Fig. 2 A and
C, white arrows). NGN2Sox10 NCCs were exclusively found
in the dorsal part of the neural crest migration stream (Fig. 2B,
arrows), and never detected near the sympathetic ganglia (SG;
Fig. 2 B and C, open arrowheads). Similarly, examination of
embryos from a conventional Ngn2lacZ knock-in line (20, 21) at
E10.5 revealed numerous lacZ cells in the dorsal root ganglia
(DRG; Fig. 2D, black arrowheads), but none in the vicinity of the
SG (Fig. 2D, white arrowheads). These data could indicate that
Ngn2-expressing cells never give rise to sympathetic neurons, or
that Ngn2 is very transiently expressed in precursors of such
autonomic neurons. To resolve this issue, we permanently
marked the progeny of Ngn2-expressing cells by injecting preg-
nant mothers carrying embryos from an Ngn2-CreERTM 
Rosa-loxPSTOPloxP-lacZ intercross with 4-OH Txf, at E9.0 (n
6 embryos) and E9.5 (n  15 embryos). In such embryos, a very
small proportion (5%) of lacZ neural crest-derived cells were
observed in the SG, identified by counterstaining with antibody
to tyrosine hydroxylase (TH; Fig. 3 C and D, arrows). Thus, some
Fig. 1. Mapping the fate of Ngn2-expressing cells. (A) Ngn2 is required for
the development of a subset of sensory neurons (NS; refs. 9 and 10), but may
be transiently expressed by progenitors with a broader developmental po-
tential (examples illustrated in 1–4). NA, autonomic neuron; G, glia. (B) Strat-
egy for inducible activation of the Rosa26-lacZ reporter gene by 4-OH Txf-
inducible Cre expressed from the Ngn2 locus. (C) Because 4-OH Txf has a
half-life in vivo of only 0.5–2 h (12), CreERTM will be active in Ngn2-expressing
cells only at the time of injection of the steroid ligand. The progeny of these
cells can be detected by expression of lacZ at later times (E12.5, blue ovals).
Other cells expressing Ngn2 at these later times will not express lacZ because
of the absence of 4-OH Txf (E12.5, white oval).
Fig. 2. Fate of transiently Ngn2-expressing cells in the neural tube. (A–C)
Double-label immunofluorescence staining of a section through the caudal
trunk region of an E9.5 mouse embryo with antibodies to NGN2 (A, green) and
the pan-neural crest marker Sox10 (B, red). White arrowheads indicates
NGN2Sox10 cells in the dorsal neural tube, open arrow indicates
NGN2Sox10 motoneuron precursors in the ventral neural tube; white ar-
rows indicate NGN2Sox10 NCCs in the dorsal migration pathway, open
arrowheads indicate NGN2Sox10 cells migrating ventrally toward the dor-
sal aorta (da). (D and E) Analysis of conventional Ngn2lacZ knock-in embryos
(20, 21). (D) At E10.5, numerous lacZ cells are visible in the DRG (black
arrowheads) and ventral nerve roots (arrows), but not in the region of the SG
(white arrowheads). (E) By E12.5, expression in the DRG is no longer detectable
(arrowheads) and there is extensive expression in the dorsolateral neural tube
(arrows). (F–J) Analysis of Ngn2CreERTM  RosaSTOPlacZ embryos injected
with 4-OH Txf at E9.5 and analyzed at E10.5 (F) or E12 5 (G–J). (F) Some
Ngn2-CreERTM-expressing cells were in the dorsal neural tube at the time of
Cre activation (arrows). (G and H) By E12.5, there are very few lacZ cells in the
dorsal neural tube and numerous labeled cells in DRG (white arrowhead) and
dorsal roots (black arrowhead); contrast this with the pattern seen when using
the conventional Ngn2lacZ reporter (E). The arrow in G indicates motorneu-
rons. (H–J) Occasional elongated, lacZ cells with an endfoot in the ventricular
zone are seen at E12.5 in the dorsal (H and I, white arrow) and ventral (H and
J, black arrow) regions of the spinal cord; I and J are higher-magnification
views of the dorsal and ventral regions of the section shown in H. Such cells are
not seen in conventional Ngn2-lacZ knock-in mice at the same age (compare
E and H).














Ngn2-expressing cells do appear to generate sympathetic
neurons.
To determine whether the relative contribution of Ngn2-
expressing cells to DRG vs. SG was quantitatively different
from the NCC population as a whole, we performed a similar
analysis on embryos containing a Wnt1-CreERTM transgene
(12). Wnt1 is expressed in the dorsal neural tube and roof-plate
from the onset of neural crest migration (22), and Wnt1-
expressing NCCs populate all of the tissues derived from the
neural crest (23). Injections of embryos from Wnt1-CreERTM
Rosa-loxPSTOPloxP-lacZ intercrosses with 4-OH Txf were
performed at similar times to those in the Ngn2-CreERTM
experiments (E8.75–E9.0 and E9.5), and the embryos were
analyzed at E12.5 (Fig. 3B).
To quantify the results, we counted the total number of lacZ
cells in the DRG plus SG in every fourth section through the
trunk region. There were many more (18-fold) lacZ neural
crest-derived cells in Wnt1-CreERTM-expressing embryos, pre-
sumably reflecting both the expression of Wnt1 in more cells than
Ngn2, and at higher levels from the multicopy transgene. There-
fore, we first normalized the data by calculating the percentage
of labeled ganglionic cells in either the DRG or SG for each
embryo, and then taking the mean of these values across all
embryos of a given genotype (n  21 Ngn2-CreERTM embryos;
n  4 Wnt1-CreERTM embryos). As expected, in Wnt1-CreERTM
embryos the average percent of cells in the DRG was 5-fold
higher than that in the SG (Table 1), reflecting the larger size of
the sensory ganglia. Furthermore, this percentage was higher
when 4-OH Txf injection was carried out at E9.5 (6.7-fold) than
at E8.75–E9.0 (3.7-fold; Table 1), consistent with the fact that
NCCs continue to populate the DRGs after they have stopped
colonizing the SGs (24, 25).
Despite this overall DRG-bias of the bulk NCC population,
however, in Ngn2-CreERTM embryos the percentage of labeled
cells in the DRG was 20-fold higher than in the SG (Table 1).
Thus, cells derived from Ngn2-expressing progenitors contrib-
uted to sensory ganglia rather than sympathetic ganglia at a
frequency 3- to 4-fold higher than that of Wnt1-expressing
progenitors, at both early and late injection times (Table 1). To
ensure that this difference was not an artifact of the smaller
number of labeled cells in Ngn2-CreERTM embryos (67 cells per
embryo in DRGSG vs. 1,258 cells per embryo in DRGSG of
Wnt1-CreERTM embryos), we performed a Monte Carlo simu-
lation to randomize the data, using the actual number of cells
counted in each of the 21 embryos examined but assuming that
the distribution of cells between the DRG and SG was actually
the same as that measured in Wnt1-CreERTM embryos [83% in
DRG, 17% in SG, a ratio of 4.8 (Table 1)]. After 10,000
iterations of this simulation, the probability that the ratio [%
cells in DRG][% in SG] of 20 that we actually measured in
Ngn2-CreERTM embryos (Table 1) was due to chance was
0.001. Consistent with this, the percentage of Wnt1-derived
cells in SG was 3.5-fold higher than the percentage of Ngn2-
derived cells in these autonomic ganglia. Thus, by several
measures NCCs expressing Ngn2 are more likely to colonize
sensory ganglia than are those expressing Wnt1. This difference
Fig. 3. Distribution of progeny derived from Ngn2CreERTM-expressing NCCs
in the PNS. All panels are from Ngn2-CreERTM  RosaSTOPlacZ embryos
injected at E9.5 and analyzed at E12.5, except for B, which is from a control
Wnt1-CreERTM  RosaSTOPlacZ embryo similarly injected and analyzed. Ar-
rows in A and B indicate DRG, arrowheads SG. (C and D) Example of a rare
section from Ngn2-CreERTM embryos with a lacZ cell in the SG (arrow),
visualized by counterstaining for TH (brown); D shows a higher-magnification
view of the SG. Arrowhead indicates DRG. See Table 1 for quantification. (E–G)
Double-labeling reveals that lacZ cells in the DRG include both neuronal
(Isl1or NeuN, arrows) and non-neuronal (Isl1or NeuN, arrowheads) cells.
NT indicates neural tube. The magnification in G is slightly higher than in F. (H
and I) Ngn2-expressing NCCs generate BFABP glial cells in dorsal root (large
arrow) and peripheral nerve (H, small arrows), as well as in the DRG. Neurons
and non-neuronal cells are generated in statistically indistinguishable pro-
portions (see Table 2).
Table 1. Relative contributions of Ngn2- and Wnt1-derived








E8.75-E9.0 11.2 3.7 3.0
E9.5 27.6 6.7 4.1
Combined 19.5 4.8 4.0
The percentage of cells in the DRG or SG was first calculated for each
embryo as [(no. cells in DRG)(no. cells in DRG  no. cells in SG)]  100% or
[(no. cells in SG)(no. cells in DRG no. cells in SG)] 100%, respectively. The
mean of this percentage was then calculated for all embryos of a given
genotype. The mean percentage of cells in the DRG, or in the SG, in Ngn2-
CreER embryos (n  21) was statistically significantly different from that in
Wnt1-CreER embryos (n  4) at all stages (P  0.01).
*The relative colonization of the DRG compared to the SG was then calculated
as the [mean % of cells in DRGmean % of cells in the SG].
†The relative preference of Ngn2-derived cells to colonize the DRG compared
to Wnt1-derived cells is calculated as the ratio of the numbers in the first two
columns.
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is likely to be an underestimate, because the Wnt1-expressing
NCC population itself presumably contains Ngn2-expressing
cells.
At the time of 4-OH-Txf injection, NGN2 cells are located in
both the dorsal and ventral neural tube, as well as in the neural
crest (Fig. 2 A–C). Strikingly, in embryos analyzed at E12.5 there
were no labeled neurons in the dorsal neural tube; rather, they
were found in neural crest derivatives and in the ventral neural
tube (Fig. 2 G and H). That reporter activation did occur in some
dorsal neural tube cells at E9.5 is supported by the fact that lacZ
cells could still be detected in this location in embryos analyzed
at E10.5 (Fig. 2F), and by the persistence at E12.5 of a few
labeled progenitor-like cells with an elongated morphology and
endfoot in the dorsal ventricular zone (Fig. 2 H and I, white
arrow). These data suggest that most NGN2 cells in the dorsal
neural tube at E9.5 may be premigratory neural crest or dual
crest-CNS progenitor cells (2, 3). However, we cannot formally
exclude that some of these cells die, or migrate ventrally.
We next asked whether there was any bias in the differenti-
ation of Ngn2-expressing cells to neuronal vs. glial fates in the
sensory ganglia. To do this, we performed double-labeling for
lacZ expression and the pan-neuronal markers Isl1 (Fig. 3 E and
F) or NeuN (Fig. 3G) to identify neurons, or anti-BFABP
antibody staining to identify peripheral glia (ref. 18; Fig. 3 H and
I). Double-labeled lacZIsl1 (or lacZNeuN) neurons were
clearly distinguishable from lacZIsl1 non-neuronal cells (Fig.
3 E–G, arrows vs. arrowheads, respectively). Expression of lacZ
in these latter, non-neuronal cells was colocalized with that of
BFABP; this was particularly clear in the dorsal roots and
peripheral nerve (Fig. 3 H and I, arrows), where there are no
neuronal cell bodies. Quantification indicated that the percent-
age of lacZ neurons and non-neuronal DRG cells was statis-
tically indistinguishable in embryos injected with 4-OH Txf at
either E9.0 or E9.5 (Table 2). A similar result was obtained in
Wnt1-CreERTM embryos (52  3% LacZIsl and 48  3%
LacZIsl cells; n  2 embryos). Therefore, Ngn2-expressing
cells give rise to both neurons and non-neuronal cells in similar
proportions, as does the bulk NCC population. These data
indicate that although Ngn2-expressing NCCs are strongly biased
toward generating sensory derivatives, they are not biased
toward generating neuronal vs. glial derivatives.
Finally, we examined the distribution of Ngn2-derived cells
among different sensory neuron subtypes by double-labeling
using antibodies to the NGF receptor trkA, the BDNF receptor
trkB, or the NT-3 receptor trkC. These receptors are predom-
inantly, although not exclusively, expressed by nociceptive,
mechanoceptive, and proprioceptive sensory neurons, respec-
tively (reviewed in ref. 26). We estimated that 68% of lacZ
neurons in the DRG are trkA (Fig. 4 A and B, arrows; n  10
embryos), a number remarkably close to the percentage of all
neurons that express the receptor at this stage (70%; ref. 27).
A much smaller proportion of lacZ cells appeared to be trkB
or trkC (Fig. 4 C–F, arrows), consistent with the fact that these
receptors are expressed by a smaller proportion of all sensory
neurons at this stage (27). Thus, these data suggest that Ngn2-
expressing NCCs contribute to multiple classes of sensory neu-
rons in DRG, without any apparent bias toward a particular
subtype.
Discussion
Classical lineage tracing studies have left open the question of
whether the premigratory and early migrating neural crest is a
homogeneous population of pleuripotent cells, or whether it is
heterogeneous and contains both pleuripotent and intrinsically
fate-restricted cells. The results presented here identify at least
one subpopulation of NCCs, namely that marked by expression
of Ngn2, which exhibits a predictable bias in its differentiated
fate from an early stage in migration. Ngn2-expressing cells are
20 times more likely to generate sensory than autonomic
(sympathetic) derivatives, and this bias is 3- to 4-fold greater than
that of bulk NCCs marked by expression of Wnt1. This conclu-
sion is supported even when taking into account the fact that
there are more labeled NCCs in Wnt1-CreERTM embryos.
The fact that even a few Ngn2-expressing NCCs give rise to
autonomic derivatives indicates that Ngn2 does not mark inevitable
commitment to a sensory fate, but rather a strong bias to such a fate.
This bias may reflect an inherently probabilistic influence of Ngn2
on sensory fate specification, or the influence of additional un-
known but deterministic factors. For example, forced expression of
Ngns promotes sensory differentiation both in vivo (28) and in
cultured PNS progenitor cells, but in vitro this effect can be
overridden by environmental signals that promote autonomic neu-
rogenesis (29). These data suggest that there are other determinants
of sensory identity required in addition to Ngns to commit cells to
Table 2. Relative contribution of Ngn2-derived neural crest cells
to neuronal vs. non-neuronal derivatives in sensory ganglia
Stage of injection
(no. of embryos) Neurons Non-neuronal cells
E9 (5) 56%  6%* 44%  6%*
E9.5 (11) 52%  5% 48%  5%
Combined 53%  4% 47%  4%
The percentage of lacZ-labeled cells that were neurons (Isl1) or non-
neuronal cells (Isl1) was measured in the DRG of Ngn2-CreER™ embryos
injected at the indicated stages; the numbers represent the mean  SEM.
*There was no statistically significant difference in the percentage of neurons
vs. non-neuronal cells at either stage. Similar results were obtained in Wnt1-
CreER™ embryos (see text).
Fig. 4. Ngn2-expressing NCCs generate multiple sensory neuron subtypes in
the DRG. Sections through DRG of E12.5 Ngn2-CreERTM embryos injected with
4-OH Txf at E9.5. (A and B) Sections double-labeled to reveal lacZ (blue) and
trkA (brown) cells at low (A) and high (B) magnification. Arrows indicate
double-positive cells, arrowheads a lacZ, trkA cell. (C and D) Double-
labeling for lacZand trkB cells. (E and F) Double-labeling for lacZand trkC
cells. In each case, analysis in multiple focal planes confirmed the colocaliza-
tion of X-gal staining and anti-trk antibody staining. Arrows indicate double-
positive cells, arrowheads a lacZtrk cell.














a sensory fate. Perhaps the small fraction of Ngn2CreERTM-
expressing NCCs that generated autonomic derivatives represents
those cells in which such putative sensory identity codeterminants
had not yet been expressed at the time of 4-OH Txf injection.
Alternatively, commitment to a sensory fate may require prolonged
or enhanced Ngn2 expression, analogous to the commitment to a
neural precursor fate of Drosophila epithelial cells expressing high
levels of proneural genes (30).
The identification of Ngn2-expressing cells as strongly biased to
a sensory fate suggests that those marked NCCs that generated only
sensory derivatives in the chick lineage tracing experiments (2–4)
may have been intrinsically restricted to this fate, and could be
equivalent to or overlapping with the Ngn2-expressing population.
The fact, moreover, that Ngn2 is expressed in premigratory as well
as in migrating NCCs (Fig. 2A; refs. 8 and 9) further suggests that
such a developmental bias may be acquired by NCCs at a relatively
early stage in their ontogeny, perhaps even before they exit the
neural tube (Fig. 5A). However, we cannot exclude that such
premigratory NGN2 cells contribute most of the sympathetic
progeny derived from the Ngn2-expressing population. Thus, the
exact time and place at which restriction to a sensory fate is imposed
remain to be determined. Whatever the case, our results suggest
that from the earliest stages of migration, the neural crest is not a
homogeneous population of pleuripotent cells, but rather contains
deterministically distinct subpopulations with predictable fate
biases.
Our results further suggest that Ngn2-expressing NCCs are not
committed to a neuronal fate, despite their bias for a sensory
identity. Consistent with this conclusion, CNS precursors isolated
on the basis of Ngn2 expression can generate glia and neurons in
vitro (31), although it was not determined whether these cells are
restricted to generating specific neuronal subtypes. Previously, we
showed that postmigratory neural crest stem cells in the sciatic
nerve are restricted to autonomic fates but can still generate both
neurons and glia (32). Those studies, however, left open the
converse question of whether all sensory progenitors also generate
autonomic derivatives, or whether there exists a complementary
population of sensory-restricted multipotent neuro-glial progeni-
tors. In vitro studies have provided evidence of sensory-restricted
progenitors, but whether these cells also generated glia could not be
determined (33). The present results indicate that sensory-
restricted precursors generate neurons and glia with equal proba-
bilities, in a similar fashion as the bulk neural crest population
marked by Wnt1 expression. Taken together, these data imply
that, at least in the PNS, multipotential neural progenitors be-
come specified for certain aspects of neuronal subtype identity
(Fig. 5B, PS and PA) before they have become committed to
neuronal or glial fates.
This conclusion challenges current models of neural cell
lineage diversification, in which progenitors are typically de-
picted as first committing to neuronal or glial fates (Fig. 5C,
PN and PG), before acquiring particular neuronal subtype
identities (reviewed in refs. 34 and 35). Evidence for such
restricted neuronal and glial precursors has been provided by
in vitro studies of embryonic spinal cord-derived progenitor
cells (36–39). However, recent studies suggest that in vivo,
spinal cord progenitors are specified for particular neuronal
and glial subtype identities before choosing between neuronal
and glial fates (40, 41). Thus, although some finer aspects of
neuronal subtype identity may not be acquired until after
precursors commit to a neuronal fate, at least certain broad
subclasses (e.g., sensory vs. autonomic, motoneuron vs. inter-
neuron) are specified while progenitors still possess both
neuronal and glial capacities. Such a decision logic could
ref lect the dual role of bHLH proneural genes in controlling
the neuron vs. glial fate decision (reviewed in ref. 42), and in
neuronal identity determination (e.g., ref. 43). The need to
coordinate the latter role with other transcriptional programs
that specify neuronal identity (21, 44) may necessitate that
such programs are established at the time proneural genes are
first expressed, when neural progenitors are competent for,
but not committed to, a neuronal fate (45).
We thank C. Schuurmans and F. Guillemot (Universite´ Louis Pasteur,
Strasbourg, France) for providing the Ngn2 genomic construct and
Ngn2-lacZ mice; P. Soriano (Fred Hutchinson Cancer Research Center,
Seattle) for Rosa26-loxp reporter mice; B. Kennedy, S. Pease, and the
staff of Transgenic Animal Facility, California Institute of Technology,
for expert help in the generation and maintenance of genetically
modified mice; L. Reichardt and F. Rice for anti-Trk antibodies; and
C. Birchmeier for the anti-BFABP antibody. We thank G. Kreiman for
help with mathematical simulations; J. Yamada for genotyping; and
S. Pintchovski and G. Mosconi for help with experiments. Work in
A.P.M.’s laboratory was supported by Grant HD 30249 from the
National Institutes of Health. D.J.A. is an Investigator of the Howard
Hughes Medical Institute.
Fig. 5. Summary diagram. (A) Illustration of experimental results. Transient
activation of Cre recombinase in Ngn2-expressing cells in the dorsal neural
tube andor migrating neural crest at E9.0–E9.5 leads to progeny that by E12.5
have predominantly populated the DRG and surrounding nerve roots; both
neurons (blue circles) and glia (blue diamonds) are found in this location. (B–D)
Possible modes of neural crest lineage segregation. (B) NCCs first generate
autonomic- and sensory-restricted progenitors (PA and PS, respectively). These
progenitors then each generate neurons (NA, NS) and glia (GA and GS). (C) NCCs
first generate neuronal- and glial-restricted progenitors (PN and PG, respec-
tively), which then differentiate into autonomic and sensory neurons or glia.
(D) NCCs directly generate autonomic and sensory neurons and glia without
restricted intermediates. (E) Wnt1 expression marks NCCs, whereas NGN2 is
predominantly expressed by sensory-restricted progenitors, favoring the
model in B. Dotted arrow indicates that some NGN2 cells can still generate
autonomic derivatives at low frequency.
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